SanBio Company Limited (TYO:4592)

SanBio Company Cash Flow Statement

Financials in millions JPY. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Net Income	-3,010	-2,542	-4,697	-4,560	-3,211
Depreciation & Amortization	9	14	24	132	74
Loss (Gain) From Sale of Assets	-2	-30	-1	10	-
Loss (Gain) From Sale of Investments	-	-	-	-	-3,318
Other Operating Activities	-18	-1	-90	-186	-16
Change in Inventory	-	-	510	3	13
Change in Accounts Payable	-172	-93	-241	78	188
Change in Other Net Operating Assets	-410	-2,113	-2,939	-2,023	1,055
Operating Cash Flow	-3,603	-4,765	-7,434	-6,546	-5,215
Capital Expenditures	-4	-11	-7	-42	-96
Sale of Property, Plant & Equipment	-	35	1	-	-
Sale (Purchase) of Intangibles	-	-43	-	-14	-42
Investment in Securities	-	-	-	-	4,318
Other Investing Activities	-	-	-4	-10	-
Investing Cash Flow	-4	-19	-10	-66	4,180
Short-Term Debt Issued	-	-	-	-	500
Long-Term Debt Issued	-	-	-	-	2,300
Total Debt Issued	-	-	-	-	2,800
Short-Term Debt Repaid	-	-	-	-500	-
Long-Term Debt Repaid	-268	-268	-1,592	-975	-2,800
Total Debt Repaid	-268	-268	-1,592	-1,475	-2,800
Net Debt Issued (Repaid)	-268	-268	-1,592	-1,475	-
Issuance of Common Stock	2,372	2,651	11,055	3	-
Other Financing Activities	-13	-13	-18	-23	-56
Financing Cash Flow	2,091	2,370	9,445	-1,495	-56
Foreign Exchange Rate Adjustments	-20	128	116	185	-73
Miscellaneous Cash Flow Adjustments	-	1	1	-1	-1
Net Cash Flow	-1,536	-2,285	2,118	-7,923	-1,165
Free Cash Flow	-3,607	-4,776	-7,441	-6,588	-5,311
Free Cash Flow Per Share	-52.38	-73.11	-128.47	-127.21	-102.56
Cash Interest Paid	8	10	25	45	49
Cash Income Tax Paid	16	-	89	187	15
Levered Free Cash Flow	-2,302	-3,316	-4,506	-4,274	-3,073
Unlevered Free Cash Flow	-2,297	-3,310	-4,490	-4,247	-3,043
Change in Working Capital	-582	-2,206	-2,670	-1,942	1,256

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.